Given the identified role of SPP1 in other cancers and its demonstrated status as a biomarker for prognosis, this study sought to examine the expression of SPP1 in LUAD, determine its relationship with clinical manifestations and prognosis, and provide a novel reference for the diagnosis and prognosis of LUAD combining bioinformatics and molecular biology. This evidence concerns the gene SPP1 and cancer.